Marshall Wace’s Centogene N.V. Common Shares CNTG Stock Holding History

Marshall Wace’s Portfolio CNTG Stock Details CNTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-18,691	Closed	-$195K	–	3526
2021 Q2	$195K	Buy	+18,691	New	+$196K	﹤0.01%	2451

Other funds holding CNTG

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace's CNTG Position: Q3 2021 in Review

Marshall Wace sold out of Centogene N.V. Common Shares (CNTG) in Q3 2021, closing a stake of 18,691 shares — an estimated $195K sold.

Marshall Wace first reported a position in CNTG in Q2 2021 and held it in 1 quarter. The position peaked at $195K in Q2 2021. 19 funds tracked by Wall St. Rank hold CNTG as of Q3 2021.

Marshall Wace reported no remaining Centogene N.V. Common Shares position as of Q3 2021 after selling out during the quarter.
Marshall Wace sold 18,691 Centogene N.V. Common Shares shares in Q3 2021, an estimated $195K.
Marshall Wace first reported a position in Centogene N.V. Common Shares in Q2 2021 and held it in 1 quarter.
Marshall Wace's Centogene N.V. Common Shares position peaked at $195K in Q2 2021.
19 funds tracked by Wall St. Rank held Centogene N.V. Common Shares as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.